Owens & Minor, Inc. (NYSE:OMI) Expected to Post Quarterly Sales of $2.28 Billion


Share on StockTwits

Equities research analysts expect Owens & Minor, Inc. (NYSE:OMI) to report $2.28 billion in sales for the current quarter, Zacks reports. Two analysts have provided estimates for Owens & Minor’s earnings. The lowest sales estimate is $2.23 billion and the highest is $2.34 billion. Owens & Minor posted sales of $2.12 billion during the same quarter last year, which suggests a positive year-over-year growth rate of 7.5%. The business is scheduled to issue its next earnings results on Wednesday, May 5th.

According to Zacks, analysts expect that Owens & Minor will report full-year sales of $9.44 billion for the current financial year, with estimates ranging from $9.41 billion to $9.47 billion. For the next year, analysts expect that the company will report sales of $9.57 billion, with estimates ranging from $9.57 billion to $9.58 billion. Zacks Investment Research’s sales averages are an average based on a survey of sell-side research firms that follow Owens & Minor.

Owens & Minor (NYSE:OMI) last issued its quarterly earnings data on Wednesday, February 24th. The company reported $1.14 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.86 by $0.28. Owens & Minor had a negative net margin of 0.72% and a positive return on equity of 18.07%. The business had revenue of $2.36 billion during the quarter, compared to the consensus estimate of $2.17 billion.

A number of equities research analysts have issued reports on the stock. Barclays upped their price objective on shares of Owens & Minor from $23.00 to $33.00 and gave the stock an “equal weight” rating in a research report on Thursday, February 25th. UBS Group raised shares of Owens & Minor from a “neutral” rating to a “buy” rating and upped their price objective for the stock from $27.00 to $37.00 in a research report on Thursday, December 17th. Robert W. Baird raised shares of Owens & Minor to an “outperform” rating and increased their target price for the company from $45.00 to $50.00 in a research report on Friday, March 26th. Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell started coverage on shares of Owens & Minor in a research report on Friday, December 11th. They set a “neutral” rating and a $30.00 target price for the company. Finally, Smith Barney Citigroup started coverage on shares of Owens & Minor in a research note on Friday, December 11th. They set a “neutral” rating and a $30.00 price target on the stock. Five analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. The company presently has a consensus rating of “Buy” and an average target price of $28.45.

OMI stock traded down $0.21 during trading on Monday, reaching $37.21. The stock had a trading volume of 17,479 shares, compared to its average volume of 1,290,262. Owens & Minor has a one year low of $5.50 and a one year high of $39.45. The company has a quick ratio of 0.70, a current ratio of 1.47 and a debt-to-equity ratio of 2.44. The company’s 50 day moving average is $34.31 and its two-hundred day moving average is $28.16. The company has a market capitalization of $2.74 billion, a price-to-earnings ratio of -37.80, a P/E/G ratio of 0.24 and a beta of 0.26.

The company also recently announced a quarterly dividend, which was paid on Wednesday, March 31st. Shareholders of record on Monday, March 15th were paid a $0.002 dividend. This represents a $0.01 annualized dividend and a yield of 0.02%. The ex-dividend date of this dividend was Friday, March 12th. Owens & Minor’s dividend payout ratio is presently 1.79%.

In related news, Director Robert J. Henkel acquired 1,000 shares of the stock in a transaction dated Friday, January 15th. The shares were purchased at an average price of $27.11 per share, for a total transaction of $27,110.00. Following the transaction, the director now owns 21,000 shares in the company, valued at approximately $569,310. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Christopher M. Lowery sold 28,078 shares of the firm’s stock in a transaction on Monday, April 5th. The shares were sold at an average price of $37.92, for a total transaction of $1,064,717.76. Following the sale, the insider now owns 327,659 shares in the company, valued at approximately $12,424,829.28. The disclosure for this sale can be found here. Insiders sold a total of 55,447 shares of company stock worth $1,984,139 over the last quarter. Corporate insiders own 2.15% of the company’s stock.

Several hedge funds have recently added to or reduced their stakes in the stock. Everence Capital Management Inc. bought a new position in shares of Owens & Minor during the 1st quarter valued at $466,000. Dimensional Fund Advisors LP grew its holdings in shares of Owens & Minor by 0.5% during the 4th quarter. Dimensional Fund Advisors LP now owns 4,381,747 shares of the company’s stock valued at $118,530,000 after purchasing an additional 20,618 shares during the last quarter. UBS Asset Management Americas Inc. grew its holdings in Owens & Minor by 10.3% in the 4th quarter. UBS Asset Management Americas Inc. now owns 79,200 shares of the company’s stock worth $2,142,000 after acquiring an additional 7,379 shares during the last quarter. Hsbc Holdings PLC bought a new stake in Owens & Minor in the 4th quarter worth $265,000. Finally, Virtu Financial LLC bought a new stake in Owens & Minor in the 4th quarter worth $723,000. 72.98% of the stock is currently owned by institutional investors.

Owens & Minor Company Profile

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers.

Read More: Market Timing – The Benefits and the Danger

Get a free copy of the Zacks research report on Owens & Minor (OMI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.